CG Oncology, Inc. (CGON) Reports Q3 Loss of $0.57
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailGet Alerts CGON Hot Sheet
Join SI Premium – FREE
CG Oncology, Inc. (NASDAQ: CGON) reported Q3 EPS of ($0.57). Revenue for the quarter came in at $1.67 million versus the consensus estimate of $20 thousand.
For earnings history and earnings-related data on CG Oncology, Inc. (CGON) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- GE Vernova Inc. (GEV) Tops Q3 EPS by 81c, Beats on Revenue; Offers FY26 Revenue Guidance
- Kimberly Clark (KMB) PT Raised to $113 at UBS
- Document Security Systems, Inc. (DMC) Reports In-Line Q3 EPS
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
